Last reviewed · How we verify
Plasmodium falciparum malaria parasite
Plasmodium falciparum malaria parasite is a Biologic drug developed by U.S. Army Medical Research and Development Command. It is currently in Phase 1 development.
At a glance
| Generic name | Plasmodium falciparum malaria parasite |
|---|---|
| Sponsor | U.S. Army Medical Research and Development Command |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- First-in-Human PfSPZ-LARC2 Vaccination/CHMI (PHASE1)
- Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults (PHASE1)
- Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso (PHASE1)
- Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
- MDA and Targeted Control Against Plasmodium Carriage in the Sahel (NA)
- Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum (PHASE1)
- A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate (PHASE1)
- FocaL Mass Drug Administration for Vivax Malaria Elimination (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Plasmodium falciparum malaria parasite CI brief — competitive landscape report
- Plasmodium falciparum malaria parasite updates RSS · CI watch RSS
- U.S. Army Medical Research and Development Command portfolio CI
Frequently asked questions about Plasmodium falciparum malaria parasite
What is Plasmodium falciparum malaria parasite?
Plasmodium falciparum malaria parasite is a Biologic drug developed by U.S. Army Medical Research and Development Command.
Who makes Plasmodium falciparum malaria parasite?
Plasmodium falciparum malaria parasite is developed by U.S. Army Medical Research and Development Command (see full U.S. Army Medical Research and Development Command pipeline at /company/u-s-army-medical-research-and-development-command).
What development phase is Plasmodium falciparum malaria parasite in?
Plasmodium falciparum malaria parasite is in Phase 1.